F.M. Goujon
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment
Papers in
-
- Eicosanoids and Hypertension Pharmacology 5
-
- Pharmacogenetics and Drug Metabolism 4
- Co-authors
- Jacques Gielen (8 shared papers)Daniel W. Nebert (2 shared papers)J. Van Cantfort (5 shared papers)P. Kremers (1 shared paper)D W Nebert (2 shared papers)Jean De Graeve (1 shared paper)J. Sele (1 shared paper)
- Journals
- Chemico-Biological Interactions (3 papers)Molecular Pharmacology (2 papers)European Journal of Biochemistry (1 paper)Journal of Biological Chemistry (1 paper)Archives of toxicology. Supplement (1 paper)
- Partner nations
- United StatesBelgium
In The Last Decade
F.M. Goujon
11 papers receiving 594 citations
Peers
Comparison fields: 5 of 63
- Pharmacology 352
- Cancer Research 246
- Biochemistry 123
- Health, Toxicology and Mutagenesis 175
- Clinical Biochemistry 32
Countries citing papers authored by F.M. Goujon
This map shows the geographic impact of F.M. Goujon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.M. Goujon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.M. Goujon more than expected).
Fields of papers citing papers by F.M. Goujon
This network shows the impact of papers produced by F.M. Goujon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.M. Goujon. The network helps show where F.M. Goujon may publish in the future.
Co-authors
The 7 scholars most cited alongside F.M. Goujon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1972 | 204 | |
| 2 | Genetic expression of aryl hydrocarbon hydroxylase induction. IV. Interaction of various compounds with different forms of cytochrome P-450 and the effect on benzo(a)pyrene metabolism in vitro. | 1972 | 157 |
| 3 | 1972 | 155 | |
| 4 | Genetic expression of aryl hydrocarbon hydroxylase induction. 3. Changes in the binding of n-octylamine to cytochrome P-450. | 1972 | 44 |
| 5 | 1981 | 28 | |
| 6 | 1972 | 13 | |
| 7 | 1979 | 13 | |
| 8 | 1979 | 12 | |
| 9 | 1980 | 8 | |
| 10 | 1980 | 5 | |
| 11 | 1972 | 4 |
About F.M. Goujon
F.M. Goujon is a scholar working on Biochemistry, Pharmacology, Health, Toxicology and Mutagenesis, Cancer Research and Organic Chemistry, having authored 11 papers that have together received 643 indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Toxic Organic Pollutants Impact (3 papers), Carcinogens and Genotoxicity Assessment (3 papers), Alcohol Consumption and Health Effects (2 papers), Biochemical effects in animals (2 papers), Free Radicals and Antioxidants (2 papers) and Effects and risks of endocrine disrupting chemicals (1 paper). The work is most often cited by research in Pharmacology (352 citations), Cancer Research (246 citations), Biochemistry (123 citations), Health, Toxicology and Mutagenesis (175 citations) and Clinical Biochemistry (32 citations). F.M. Goujon has collaborated with scholars based in United States and Belgium. Frequent co-authors include Jacques Gielen, Daniel W. Nebert, J. Van Cantfort, P. Kremers, D W Nebert, Jean De Graeve and J. Sele. Their work appears in journals such as Chemico-Biological Interactions, Molecular Pharmacology, European Journal of Biochemistry, Journal of Biological Chemistry and Archives of toxicology. Supplement.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.